Aphria and Rapid Dose Therapeutics To Introduce ‘QuickStrip’ Oral Thin Strips To German Cannabis Market

LEAMINGTON, ONand BURLINGTON, ON, Dec. 18, 2018 /CNW/ -Aphria Inc. ("Aphria" or the "Company") (TSX:APHA, NYSE:APHA) and Rapid Dose Therapeutics Inc. ("RDT") (CSE:DOSE) announced today that they have expanded the scope of their previously announced agreement (the "Agreement") expanding the territory where Aphria has been granted exclusive preferred rights to license, manufacture, distribute and sell RDT's QuickStrip™ innovative, proprietary delivery technology for the cannabis market to Germany.

RDT's proprietary QuickStrip™ technology is a Quick, Convenient, Precise, Discreet™ oral fast-dissolving drug delivery system that offers a smoke-free choice to consumers. Aphria expects to produce and distribute CBD-only Quickstrips™ in Germany by Spring 2019.